TEVA PHARMACEUTICAL FIN LLC

Historical 13F Holders

CUSIP
88163VAE9
All holders as of
Q3 2022
Type
Debt
Class
DBCV 0.250% 2/0
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q3 10 22.1 M $17.6 M
2022 Q2 10 22.1 M $21.5 M
2022 Q1 11 22.3 M $21.8 M
2021 Q4 12 37.9 M $37.1 M
2021 Q3 11 25.3 M $24.9 M
2021 Q2 11 22.3 M $22.0 M
2021 Q1 12 25.3 M $25.2 M
2020 Q4 48 494 M $505 M
2020 Q3 49 423 M $424 M
2020 Q2 50 418 M $437 M
2020 Q1 56 417 M $398 M
2019 Q4 58 400 M $2.68 B
2019 Q3 60 387 M $365 M
2019 Q2 61 406 M $376 M
2019 Q1 51 423 M $462 M
2018 Q4 54 478 M $391 M
2018 Q3 55 421 M $682 M
2018 Q2 59 423 M $421 M
2018 Q1 59 405 M $388 M
2017 Q4 63 413 M $398 M
2017 Q3 53 448 M $448 M
2017 Q2 48 492 M $570 M
2017 Q1 48 472 M $542 M
2016 Q4 46 438 M $518 M
2016 Q3 43 435 M $554 M
2016 Q2 47 441 M $594 M
2016 Q1 50 423 M $591 M
2015 Q4 52 447 M $764 M
2015 Q3 51 445 M $645 M
2015 Q2 53 441 M $624 M
2015 Q1 48 403 M $602 M
2014 Q4 45 324 M $454 M
2014 Q3 43 391 M $506 M
2014 Q2 44 406 M $523 M
2014 Q1 40 361 M $463 M